• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

Hepatitis-B reactivation and rituximab-containing chemotherapy: An increasingly complex clinical challenge

PA Thompson, CS Tam, K Thursky, JF Seymour

Leukemia and Lymphoma | TAYLOR & FRANCIS LTD | Published : 2010

DOI: 10.3109/10428194.2010.509456

University of Melbourne Researchers

Philip Thompson's Profile Picture
Philip Thompson Author

Constantine Tam's Profile Picture
Constantine Tam Author

Kas Thursky's Profile Picture
Kas Thursky Author

John Seymour's Profile Picture
John Seymour Author

Citation metrics

7Scopus
5Web of Science
8Dimensions

Keywords

Cancer-Patients
6.1 Pharmaceuticals
Digestive Diseases
Liver Disease
Carriers
Life Sciences & Biomedicine
Hbv Reactivation
Virus Reactivation
Hematology
Oncology
Hepatitis
Hepatitis - C
Prophylactic Lamivudine
3 Good Health and Well Being
Risk
3201 Cardiovascular Medicine and Haematology
Science & Technology
Cytotoxic Chemotherapy
Chronic Liver Disease and Cirrhosis
Hepatitis - B
Lymphoma
Emerging Infectious Diseases
Cancer
Infectious Diseases
32 Biomedical and Clinical Sciences
Surface-Antigen
Preemptive Lamivudine

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224